ARTICLE | Distillery Therapeutics
Cancer
August 16, 2017 6:00 PM UTC
In vitro, cell culture and mouse studies identified a PLK1 inhibitor that could help treat KRAS-driven colorectal and pancreatic cancers. Screening of a library of 120,000 drug-like molecules an in vi...
BCIQ Company Profiles